Cargando…
Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy
OBJECTIVE: We aimed to investigate the potential risk factors for residual lesions after uterine artery chemotherapy and embolization (UACE) in combination with dilatation and curettage (D&C) in patients with cesarean scar pregnancy (CSP). SETTINGS: Retrospective case-control study. METHOD: Univ...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040523/ https://www.ncbi.nlm.nih.gov/pubmed/31195943 http://dx.doi.org/10.2174/1566524019666190612135728 |
_version_ | 1783501007041331200 |
---|---|
author | Cheng, Feng Shan, Dan Guo, Sijia Cheng, Shuang Yang, Hongwei Han, Jialin Hu, Tongxiu |
author_facet | Cheng, Feng Shan, Dan Guo, Sijia Cheng, Shuang Yang, Hongwei Han, Jialin Hu, Tongxiu |
author_sort | Cheng, Feng |
collection | PubMed |
description | OBJECTIVE: We aimed to investigate the potential risk factors for residual lesions after uterine artery chemotherapy and embolization (UACE) in combination with dilatation and curettage (D&C) in patients with cesarean scar pregnancy (CSP). SETTINGS: Retrospective case-control study. METHOD: Univariate analysis and logistic analysis were applied to analyze these data to assess the risk factor of residue after UACE in combination with D&C. RESULTS: Gestational age, human chorionic gonadotropin (HCG) level, and the gestation sac (GS) evagination to the bladder were the risk factors for the postoperative lesion. The most relevant was GS evagination to the bladder, followed by the preoperative HCG level and the gestational age. We defined the cut-off value of gestational age as 28 days with a sensitivity and specificity of 100 and 0, respectively. CONCLUSION: In cases with GS evagination to bladder and HCG of >28,113.65 mIU/ml as well as a gestational age of >28 days, the possibility of residual lesions was high. |
format | Online Article Text |
id | pubmed-7040523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-70405232020-03-13 Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy Cheng, Feng Shan, Dan Guo, Sijia Cheng, Shuang Yang, Hongwei Han, Jialin Hu, Tongxiu Curr Mol Med Article OBJECTIVE: We aimed to investigate the potential risk factors for residual lesions after uterine artery chemotherapy and embolization (UACE) in combination with dilatation and curettage (D&C) in patients with cesarean scar pregnancy (CSP). SETTINGS: Retrospective case-control study. METHOD: Univariate analysis and logistic analysis were applied to analyze these data to assess the risk factor of residue after UACE in combination with D&C. RESULTS: Gestational age, human chorionic gonadotropin (HCG) level, and the gestation sac (GS) evagination to the bladder were the risk factors for the postoperative lesion. The most relevant was GS evagination to the bladder, followed by the preoperative HCG level and the gestational age. We defined the cut-off value of gestational age as 28 days with a sensitivity and specificity of 100 and 0, respectively. CONCLUSION: In cases with GS evagination to bladder and HCG of >28,113.65 mIU/ml as well as a gestational age of >28 days, the possibility of residual lesions was high. Bentham Science Publishers 2019-08 2019-08 /pmc/articles/PMC7040523/ /pubmed/31195943 http://dx.doi.org/10.2174/1566524019666190612135728 Text en © 2019 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Cheng, Feng Shan, Dan Guo, Sijia Cheng, Shuang Yang, Hongwei Han, Jialin Hu, Tongxiu Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy |
title | Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy |
title_full | Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy |
title_fullStr | Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy |
title_full_unstemmed | Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy |
title_short | Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy |
title_sort | risk factor for residue after uterine artery chemotherapy and embolization in combination with dilatation and curettage for treating caesarean scar pregnancy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040523/ https://www.ncbi.nlm.nih.gov/pubmed/31195943 http://dx.doi.org/10.2174/1566524019666190612135728 |
work_keys_str_mv | AT chengfeng riskfactorforresidueafteruterinearterychemotherapyandembolizationincombinationwithdilatationandcurettagefortreatingcaesareanscarpregnancy AT shandan riskfactorforresidueafteruterinearterychemotherapyandembolizationincombinationwithdilatationandcurettagefortreatingcaesareanscarpregnancy AT guosijia riskfactorforresidueafteruterinearterychemotherapyandembolizationincombinationwithdilatationandcurettagefortreatingcaesareanscarpregnancy AT chengshuang riskfactorforresidueafteruterinearterychemotherapyandembolizationincombinationwithdilatationandcurettagefortreatingcaesareanscarpregnancy AT yanghongwei riskfactorforresidueafteruterinearterychemotherapyandembolizationincombinationwithdilatationandcurettagefortreatingcaesareanscarpregnancy AT hanjialin riskfactorforresidueafteruterinearterychemotherapyandembolizationincombinationwithdilatationandcurettagefortreatingcaesareanscarpregnancy AT hutongxiu riskfactorforresidueafteruterinearterychemotherapyandembolizationincombinationwithdilatationandcurettagefortreatingcaesareanscarpregnancy |